AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Neurocrine Biosciences, Inc.
$146.10
+$5.50 (+3.91%)
Previous Close
$146.38
Day Range
$145.88$149.25
Year Range
$122.14$186.12
Market Cap
14.85B
AVG Volume
1.26M
Trailing/Forward PE
20.72/15.32
PEG ratio
0.5
Dividend Yield
-
Next Earnings Date
2026-11-02
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: NBIX
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 2 Nov 2026.
Video analysis: NBIX
All videosNo video analysis for this stock yet. Request one from our team.
News: NBIX
Similar companies
-
Supernus Pharmaceuticals, Inc.
SUPN
·
NASDAQ
Compare
-
Jazz Pharmaceuticals plc
JAZZ
·
NASDAQ
Compare
-
Vanda Pharmaceuticals Inc.
VNDA
·
NASDAQ
Compare
-
Axsome Therapeutics, Inc.
AXSM
·
NASDAQ
Compare
-
Acadia Pharmaceuticals Inc.
ACAD
·
NASDAQ
Compare
-
Rapport Therapeutics, Inc. Common Stock
RAPP
·
NASDAQ
Compare